{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:33:46Z","timestamp":1790645626848,"version":"4.1.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0301-4738.195006","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:42:41Z","timestamp":1480552961000},"page":"762","source":"Crossref","is-referenced-by-count":10,"title":["Effect of prophylactic intraocular pressure-lowering medication (brinzolamide) on intraocular pressure after ranibizumab intravitreal injection: A case\u2013control study"],"prefix":"10.4103","volume":"64","author":[{"given":"Hong","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-bing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.195006-1","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/bjo.2007.130260","article-title":"Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results","author":"Arias","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.195006-2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/IAE.0b013e31802eff83","article-title":", Cardillo JA, Scott IU.Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study","author":"Costa","year":"2007","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.195006-3","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2147\/OPTH.S17423","article-title":"Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema","author":"Bandello","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/0301-4738.195006-4","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.195006-5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1167\/iovs.04-0162","article-title":"Ocular rigidity in living human eyes","author":"Pallikaris","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.195006-6","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1600-0420.2007.00939.x","article-title":"Effect of intravitreal injections and volume changes on intraocular pressure: Clinical results and biomechanical model","author":"Kotliar","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"key-10.4103\/0301-4738.195006-7","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/IJG.0b013e31819c4893","article-title":"Short-term effect of intravitreal injection of ranibizumab (Lucentis) on intraocular pressure","author":"Gismondi","year":"2009","journal-title":"J Glaucoma"},{"key":"key-10.4103\/0301-4738.195006-8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bjo.2007.126193","article-title":"Short-term intraocular pressure trends following intravitreal injections of ranibizumab (Lucentis) for the treatment of wet age-related macular degeneration","author":"Mojica","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.195006-9","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1097\/IAE.0b013e318217ffde","article-title":"Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib","author":"Choi","year":"2011","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.195006-10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/IJG.0b013e31820d7d19","article-title":"Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration","author":"Tseng","year":"2012","journal-title":"J Glaucoma"},{"key":"key-10.4103\/0301-4738.195006-11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/IAE.0000000000000520","article-title":"Sustained elevation of intraocular pressure after intravitreal anti-vegf agents: What Is the Evidence?","author":"Dedania","year":"2015","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.195006-12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/ICU.0000000000000036","article-title":"The link between intravitreal antivascular endothelial growth factor injections and glaucoma","author":"SooHoo","year":"2014","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.4103\/0301-4738.195006-13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/bjo.48.5.237","article-title":"Effects of transient induced elevation of the intra-ocular pressure on the visual field","author":"Tsamparlakis","year":"1964","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.195006-14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1055\/s-0029-1245201","article-title":"Effect of brimonidine\/timolol fixed combination on preventing the short-term intraocular pressure increase after intravitreal injection of ranibizumab","author":"Theoulakis","year":"2010","journal-title":"Klin Monbl Augenheilkd"},{"key":"key-10.4103\/0301-4738.195006-15","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/archophthalmol.2010.297","article-title":"Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections","author":"Frenkel","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.195006-16","doi-asserted-by":"crossref","unstructured":"Heier JS, Antoszyk AN, Pavan PR, Leff SR, Rosenfeld PJ, Ciulla TA, et al. Ranibizumab for treatment of neovascular age-related macular degeneration: A phase I\/II multicenter, controlled, multidose study. Ophthalmology 2006;113:633.e1-4.","DOI":"10.1016\/j.ophtha.2005.10.052"},{"key":"key-10.4103\/0301-4738.195006-17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ajo.2005.07.053","article-title":"Short-term intraocular pressure trends following intravitreal pegaptanib (Macugen) injection","author":"Hariprasad","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.195006-18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/08820538.2012.754479","article-title":"Effect of Dorzolamide\/Timolol or Brinzolamide\/Timolol prophylaxis on intravitreal anti-VEGF injection-induced intraocular hypertension","author":"Kim","year":"2013","journal-title":"Semin Ophthalmol"},{"key":"key-10.4103\/0301-4738.195006-19","doi-asserted-by":"crossref","unstructured":"Kim JE, Mantravadi AV, Hur EY, Covert DJ. Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol 2008;146:930-4.e1.","DOI":"10.1016\/j.ajo.2008.07.007"},{"key":"key-10.4103\/0301-4738.195006-20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5301\/ejo.5000455","article-title":"Effect of prophylactic medication and influence of vitreous reflux in pressure rise after intravitreal injections of anti-VEGF drugs","author":"Carnota-M\u00e9ndez","year":"2014","journal-title":"Eur J Ophthalmol"},{"key":"key-10.4103\/0301-4738.195006-21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00061198-200004000-00002","article-title":"Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma","author":"Asrani","year":"2000","journal-title":"J Glaucoma"},{"key":"key-10.4103\/0301-4738.195006-22","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/eye.2014.180","article-title":"Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients","author":"Murray","year":"2014","journal-title":"Eye (Lond)"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:22:28Z","timestamp":1786713748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0301-4738.195006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"alternative-id":["195006"],"URL":"https:\/\/doi.org\/10.4103\/0301-4738.195006","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}